Loading...
 

Volume 35, Issue 1, March 2024



Sign in to download the Issue in PDF format.

Back to the list
Mediterr J Rheumatol 2024;35(1):108-14
Article Links
Clinical Characteristics and Outcomes of Interstitial Lung Disease in Primary Sjögren's Syndrome: A Retrospective Cohort Study
Prathyusha Manikuppam1, Shivraj Padiyar1, Bijesh Yadav2, Avinash A. Nair3, Manisha Mane4, John Mathew1
Authors Information

1Department of Clinical Immunology and Rheumatology, Christian Medical College, Vellore, India

2Department of Biostatistics, Christian Medical College, Vellore, India

3Department of Pulmonary Medicine, Christian Medical College, Vellore, India

4Department of Radiology, Christian Medical College, Vellore, India

 

P Manikuppam, S Padiyar, B Yadav, A Nair, M Mane, J Mathew

Keywords: interstitial lung disease, mycophenolate mofetil, spirometry, Sjögren’s syndrome
References
  1. Fox RI. Sjögren’s syndrome. Lancet Lond Engl 2005 Jul 23;366(9482):321–31.
  2. Sandhya P, Janardana R, Sudarsanam T, Mahasampath G, Prakash JAJ, Danda D. Determinants of diagnosis and disease course in primary Sjögren’s syndrome: Results from datamining of electronic health records. Int J Rheum Dis 2019;22(9):1768–74.
  3. Flores-Chávez A, Kostov B, Solans R, Fraile G, Maure B, Feijoo-Massó C, et al., GEAS-SS SEMI Registry. Severe, life-threatening phenotype of primary Sjögren’s syndrome: clinical characterisation and outcomes in 1580 patients (GEAS-SS Registry). Clin Exp Rheumatol 2018 Jun;36 Suppl 112(3):121–9.
  4. Fox RI. Extraglandular Manifestations of Sjögren’s Syndrome (SS): Dermatologic, Arthritic, Endocrine, Pulmonary, Cardiovascular, Gastroenterology, Renal, Urology, and Gynecologic Manifestations. Sjögren’s Syndr 2011 Apr 12;285–316.
  5. Gardiner P, Ward C, Allison A, Ashcroft T, Simpson W, Walters H, et al. Pleuropulmonary abnormalities in primary Sjögren's syndrome. J Rheumatol 1993 May;20(5):831-7.
  6. Kreider M, Highland K. Pulmonary involvement in Sjögren syndrome. Semin Respir Crit Care Med 2014 Apr;35(2):255–64.
  7. He C, Chen Z, Liu S, Chen H, Zhang F. Prevalence and risk factors of interstitial lung disease in patients with primary Sjögren’s syndrome: A systematic review and meta-analysis. Int J Rheum Dis 2020 Aug;23(8):1009–18.
  8. Liebow AA, Carrington CB. Diffuse pulmonary lymphoreticular infiltrations associated with dysproteinemia. Med Clin North Am 1973 May;57(3):809–43.
  9. Gupta S, Ferrada MA, Hasni SA. Pulmonary Manifestations of Primary Sjögren's Syndrome: Underlying Immunological Mechanisms, Clinical Presentation, and Management. Front Immunol 2019 Jun 12;10:1327.
  10. Flament T, Bigot A, Chaigne B, Henique H, Diot E, Marchand-Adam S. Pulmonary manifestations of Sjögren’s syndrome. Eur Respir Rev 2016 Jun 1;25(140):110–23.
  11. Wang Y, Hou Z, Qiu M, Ye Q. Risk factors for primary Sjögren syndrome-associated interstitial lung disease. J Thorac Dis 2018 Apr;10(4):2108–17.
  12. Gao H, Zhang XW, He J, Zhang J, An Y, Sun Y, et al. Prevalence, risk factors, and prognosis of interstitial lung disease in a large cohort of Chinese primary Sjögren syndrome patients: A case-control study. Medicine (Baltimore) 2018 Jun;97(24):e11003.
  13. Buvry C, Cassagnes L, Tekath M, Artigues M, Pereira B, et al. Anti-Ro52 antibodies are a risk factor for interstitial lung disease in primary Sjögren syndrome. Respir Med 2020 Mar;163:105895.
  14. Graham BL, Steenbruggen I, Miller MR, et al. Standardization of Spirometry 2019 Update. An Official American Thoracic Society and European Respiratory Society Technical Statement. Am J Respir Crit Care Med 2019;200(8):e70-e88. doi:10.1164/rccm.201908-1590ST
  15. Strimlan CV, Rosenow EC 3rd, Divertie MB, Harrison EG Jr. Pulmonary manifestations of Sjögren's syndrome. Chest 1976 Sep;70(03):354-61.
  16. Constantopoulos SH, Papadimitriou CS, Moutsopoulos HM. Respiratory manifestations in primary Sjögren's syndrome. A clinical, functional, and histologic study. Chest 1985 Aug;88(2):226-9.
  17. Shi JH, Liu HR, Xu WB, Feng RE, Zhang ZH, Tian XL, et al. Pulmonary manifestations of Sjögren's syndrome. Respiration 2009;78(4):377-86.
  18. Ramos-Casals M, Brito-Zerón P, Seror R, Bootsma H, Bowman SJ, Dörner T, et al. Characterization of systemic disease in primary Sjögren’s syndrome: EULAR-SS Task Force recommendations for articular, cutaneous, pulmonary and renal involvements. Rheumatology 2015 Dec 1;54(12):2230–8.
  19. Manfredi A, Vacchi C, DellaCasa G, Cerri S, Cassone G, Di Cecco G, et al. Fibrosing interstitial lung disease in primary Sjogren syndrome. Joint Bone Spine 2021 Dec;88(6):105237.
  20. Davidson B, Kelly C, Griffiths I. Ten year follow up of pulmonary function in patients with primary Sjögren’s syndrome. Ann Rheum Dis 2000 Sep;59(9):709–12.
  21. Roca F, Dominique S, Schmidt J, Smail A, Duhaut P, Lévesque H, et al. Interstitial lung disease in primary Sjögren's syndrome. Autoimmun Rev 2017 Jan;16(1):48-54.
  22. Amlani B, Elsayed G, Barvalia U, Kanne JP, Meyer KC, Sandbo N, et al. Treatment of primary sjögren's syndrome-related interstitial lung disease: a retrospective cohort study. Sarcoidosis Vasc Diffuse Lung Dis 2020;37(2):136-47.
  23. Sogkas G, Hirsch S, Olsson KM, Hinrichs JB, Thiele T, Seeliger T, et al. Lung Involvement in Primary Sjögren's Syndrome-An Under-Diagnosed Entity. Front Med (Lausanne) 2020;7:332. Published 2020 Jul 16. doi:10.3389/fmed.2020.00332
  24. Parambil JG, Myers JL, Lindell RM, Matteson EL, Ryu JH. Interstitial lung disease in primary Sjögren syndrome. Chest 2006 Nov;130(5):1489-95.
  25. Yazisiz V, Göçer M, Erbasan F, Uçar İ, Aslan B, Oygen Ş, et al. Survival analysis of patients with Sjögren’s syndrome in Turkey: a tertiary hospital-based study. Clin Rheumatol 2020 Jan;39(1):233–41.
  26. Chen MH, Chen CK, Chou HP, Chen MH, Tsai CY, Chang DM. Rituximab therapy in primary Sjögren's syndrome with interstitial lung disease: a retrospective cohort study. Clin Exp Rheumatol 2016 Nov-Dec;34(6):1077-84.